vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $30.3M, roughly 1.3× SYPRIS SOLUTIONS INC). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -12.9%, a 48.8% gap on every dollar of revenue. On growth, SYPRIS SOLUTIONS INC posted the faster year-over-year revenue change (-9.5% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-1.5M). Over the past eight quarters, SYPRIS SOLUTIONS INC's revenue compounded faster (-7.7% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
SBC vs SYPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $30.3M |
| Net Profit | $14.2M | $-3.9M |
| Gross Margin | 73.1% | 4.6% |
| Operating Margin | 32.5% | -10.9% |
| Net Margin | 35.9% | -12.9% |
| Revenue YoY | -10.9% | -9.5% |
| Net Profit YoY | 117.2% | -2992.6% |
| EPS (diluted) | $0.15 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.6M | $30.3M | ||
| Q3 25 | $43.4M | $28.7M | ||
| Q2 25 | $43.4M | $31.4M | ||
| Q1 25 | $47.3M | $29.5M | ||
| Q4 24 | $44.4M | $33.4M | ||
| Q3 24 | $53.1M | $35.7M | ||
| Q2 24 | $53.1M | $35.5M | ||
| Q1 24 | $54.8M | $35.6M |
| Q4 25 | $14.2M | $-3.9M | ||
| Q3 25 | $12.8M | $517.0K | ||
| Q2 25 | $2.5M | $-2.1M | ||
| Q1 25 | $21.5M | $-899.0K | ||
| Q4 24 | $6.5M | $135.0K | ||
| Q3 24 | $2.8M | $390.0K | ||
| Q2 24 | $18.5M | $16.0K | ||
| Q1 24 | $18.8M | $-2.2M |
| Q4 25 | 73.1% | 4.6% | ||
| Q3 25 | 70.6% | 7.2% | ||
| Q2 25 | 69.2% | 8.2% | ||
| Q1 25 | 79.7% | 11.4% | ||
| Q4 24 | 76.3% | 16.1% | ||
| Q3 24 | 81.5% | 16.8% | ||
| Q2 24 | 74.2% | 15.9% | ||
| Q1 24 | 72.1% | 8.1% |
| Q4 25 | 32.5% | -10.9% | ||
| Q3 25 | 36.6% | -6.1% | ||
| Q2 25 | 33.6% | -4.6% | ||
| Q1 25 | 51.1% | -0.4% | ||
| Q4 24 | 10.6% | 3.9% | ||
| Q3 24 | 26.1% | 4.8% | ||
| Q2 24 | 51.4% | 3.6% | ||
| Q1 24 | 44.6% | -3.9% |
| Q4 25 | 35.9% | -12.9% | ||
| Q3 25 | 29.6% | 1.8% | ||
| Q2 25 | 5.7% | -6.5% | ||
| Q1 25 | 45.4% | -3.0% | ||
| Q4 24 | 14.7% | 0.4% | ||
| Q3 24 | 5.3% | 1.1% | ||
| Q2 24 | 34.8% | 0.0% | ||
| Q1 24 | 34.2% | -6.2% |
| Q4 25 | $0.15 | $-0.17 | ||
| Q3 25 | $0.12 | $0.02 | ||
| Q2 25 | $0.02 | $-0.09 | ||
| Q1 25 | $0.21 | $-0.04 | ||
| Q4 24 | $0.05 | $0.00 | ||
| Q3 24 | $0.03 | $0.02 | ||
| Q2 24 | $0.20 | $0.00 | ||
| Q1 24 | $0.20 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | — |
| Total DebtLower is stronger | $42.8M | — |
| Stockholders' EquityBook value | $248.3M | $17.8M |
| Total Assets | $380.4M | $107.8M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.1M | — | ||
| Q3 25 | $127.4M | — | ||
| Q2 25 | $152.7M | — | ||
| Q1 25 | $132.1M | — | ||
| Q4 24 | $125.0M | — | ||
| Q3 24 | $137.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $42.8M | — | ||
| Q3 25 | $21.1M | — | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $823.2K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $248.3M | $17.8M | ||
| Q3 25 | $248.0M | $20.0M | ||
| Q2 25 | $244.6M | $18.7M | ||
| Q1 25 | $226.4M | $19.0M | ||
| Q4 24 | $195.1M | $19.6M | ||
| Q3 24 | $205.0M | $18.2M | ||
| Q2 24 | $8.8M | $19.0M | ||
| Q1 24 | $9.0M | $20.8M |
| Q4 25 | $380.4M | $107.8M | ||
| Q3 25 | $321.4M | $112.5M | ||
| Q2 25 | $315.3M | $105.8M | ||
| Q1 25 | $284.6M | $110.2M | ||
| Q4 24 | $266.1M | $119.4M | ||
| Q3 24 | $296.5M | $121.6M | ||
| Q2 24 | $19.5M | $124.2M | ||
| Q1 24 | $19.8M | $129.0M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $-1.1M |
| Free Cash FlowOCF − Capex | $51.2M | $-1.5M |
| FCF MarginFCF / Revenue | 129.3% | -5.0% |
| Capex IntensityCapex / Revenue | 2.0% | 1.3% |
| Cash ConversionOCF / Net Profit | 3.66× | — |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $-1.1M | ||
| Q3 25 | $-20.9M | $-178.0K | ||
| Q2 25 | $-8.3M | $1.1M | ||
| Q1 25 | $1.9M | $-5.5M | ||
| Q4 24 | $-7.3M | $2.3M | ||
| Q3 24 | $5.0M | $-4.8M | ||
| Q2 24 | $19.2M | $6.2M | ||
| Q1 24 | $3.7M | $-1.7M |
| Q4 25 | $51.2M | $-1.5M | ||
| Q3 25 | $-20.9M | $-390.0K | ||
| Q2 25 | $-8.6M | $941.0K | ||
| Q1 25 | $1.7M | $-5.5M | ||
| Q4 24 | $-7.9M | $1.9M | ||
| Q3 24 | $4.6M | $-4.9M | ||
| Q2 24 | $18.3M | $6.0M | ||
| Q1 24 | $3.0M | $-2.0M |
| Q4 25 | 129.3% | -5.0% | ||
| Q3 25 | -48.3% | -1.4% | ||
| Q2 25 | -19.9% | 3.0% | ||
| Q1 25 | 3.5% | -18.8% | ||
| Q4 24 | -17.8% | 5.7% | ||
| Q3 24 | 8.7% | -13.8% | ||
| Q2 24 | 34.5% | 16.8% | ||
| Q1 24 | 5.4% | -5.7% |
| Q4 25 | 2.0% | 1.3% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.7% | 0.5% | ||
| Q1 25 | 0.5% | 0.0% | ||
| Q4 24 | 1.3% | 1.2% | ||
| Q3 24 | 0.8% | 0.4% | ||
| Q2 24 | 1.6% | 0.5% | ||
| Q1 24 | 1.3% | 0.9% |
| Q4 25 | 3.66× | — | ||
| Q3 25 | -1.63× | -0.34× | ||
| Q2 25 | -3.39× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | -1.12× | 17.13× | ||
| Q3 24 | 1.77× | -12.21× | ||
| Q2 24 | 1.04× | 385.25× | ||
| Q1 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
